Medications

Japan prosecutors raid Novartis over drug ad scandal

Japanese prosecutors on Wednesday raided the offices of the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, local media said.

Medications

FDA warns against misuse of laxatives

(HealthDay)—If you are constipated and need to use a laxative, the U.S. Food and Drug Administration wants you to know that some products can be dangerous if you don't follow the dosing instructions or you have certain ...

Medications

Japan files criminal complaint against Novartis arm

Japan's health ministry on Thursday filed a criminal complaint against the local arm of Swiss pharmaceutical giant Novartis over alleged exaggerated advertising for a popular blood-pressure drug, the company said.

Oncology & Cancer

Scientists make advance in cancer research

A protein that has been at the centre of cancer drug design for the last 20 years should not be given up on according to new research from the University of East Anglia (UEA). The most advanced version of αvβ3-integrin ...

Cardiology

Higher blood pressure threshold OK in older adults (Update)

Many older adults with high blood pressure can be treated less aggressively, which could mean taking fewer pills to get it under control, according to new treatment guidelines from a U.S. expert panel. But not all experts ...

Alzheimer's disease & dementia

Promising Alzheimer's drug trialled in a large EU study

An extensive European study is currently investigating whether a drug used to treat high blood pressure may also help patients with Alzheimer's disease. The EU is investing almost 6 million euros on the project, in which ...

Oncology & Cancer

Nexavar approval expanded for common thyroid cancer

(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.

page 38 from 40